Minulet (Ethinylestradiol, Gestodene)

Ethinylestradiol and Gestodene, the active ingredients in Minulet, are a combined oral contraceptive presented as oral tablets for oral use. They are indicated for preventing pregnancy in women of reproductive age and may also be used to regulate menstrual cycles.

GNH USA supplies Minulet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable global distribution.

Minulet, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent pregnancy.

Contraception: provides reliable prevention of pregnancy by inhibiting ovulation. Menstrual cycle regulation: helps achieve more regular menstrual bleeding patterns. Acne management: can improve acne associated with hormonal fluctuations.

Common Side Effects: - Nausea or mild gastrointestinal upset. - Breast tenderness or enlargement. - Headache or migraine. - Breakthrough or spotting bleeding. - Mood changes or irritability. - Weight fluctuation.

Serious or Rare Side Effects: - Venous thromboembolism (deep vein thrombosis, pulmonary embolism). - Arterial thrombosis (stroke, myocardial infarction). - Severe hypertension. - Liver adenoma or hepatocellular carcinoma. - Allergic reactions such as rash, angioedema, or anaphylaxis. - Severe depression or mood disorders.

Before prescribing Minulet, clinicians should consider the following precautions: - Assess thrombotic risk: evaluate personal or family history of clotting disorders. - Screen for hypertension: monitor blood pressure regularly. - Avoid smoking: especially in women over 35 years of age. - Evaluate liver function: contraindicated in active hepatic disease. - Store at ambient temperature: keep below 25°C, protect from moisture and keep in the original packaging.

Minulet may interact with several medicines that alter its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine, phenytoin) may markedly reduce contraceptive effectiveness. - St. John’s wort can decrease plasma levels of the hormones, compromising contraception. - Protease inhibitors (e.g., ritonavir) may increase hormone concentrations, raising the risk of adverse events.

Moderate Interactions (Monitor Closely): - Antihypertensives may experience reduced blood‑pressure control. - NSAIDs can increase gastrointestinal irritation and bleeding risk. - Glucocorticoids may augment the risk of thromboembolic events.